|
|
|
|
EloxatinScoop.co.nz (press release), ...metastatic colorectal cancer. The change will see oxaliplatin (Eloxatin) made available as a first-line treatment. PHARMAC Medical ... Dyax Corp. and Debiopharm SA Restructure Development Agreement for ... Dec 20, 2005 Finanzen.net, Debiopharm has developed and registered three products withcombined sales in excess of $1.8bn in 2004: Eloxatin(R), one ofsanofi-aventis' leading marketed ... Debiopharm SA and Dyax Corp. Restructure Development Agreement for ... Dec 20, 2005 Yahoo! News (press release) Debiopharm has developed and registered three products with combined sales in excess of $1.8bn in 2004: Eloxatin®, one of sanofi-aventis' leading marketed ... NCCN Updates Colon Cancer Guidelines Dec 22, 2005 Business Wire (press release), The panel also added a new regimen, capecitabine (Xeloda) and oxaliplatin (Eloxatin) also known as CAPOX as a treatment option in first-line therapy. ... |
|
Home Copyright phasechange.org 2006. All Rights Reserved. |